These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 30904991)

  • 21. Is it the right time for an infant screening for Duchenne muscular dystrophy?
    Vita GL; Vita G
    Neurol Sci; 2020 Jul; 41(7):1677-1683. PubMed ID: 32112218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Newborn Screening for Spinal Muscular Atrophy: Ontario Testing and Follow-up Recommendations.
    McMillan HJ; Kernohan KD; Yeh E; Amburgey K; Boyd J; Campbell C; Dowling JJ; Gonorazky H; Marcadier J; Tarnopolsky MA; Vajsar J; MacKenzie A; Chakraborty P
    Can J Neurol Sci; 2021 Jul; 48(4):504-511. PubMed ID: 33059774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two years of newborn screening for Duchenne muscular dystrophy as a part of the statewide Early Check research program in North Carolina.
    Kucera KS; Boyea BL; Migliore B; Potter SN; Robles VR; Kutsa O; Cope H; Okoniewski KC; Wheeler A; Rehder CW; Smith EC; Peay HL
    Genet Med; 2024 Jan; 26(1):101009. PubMed ID: 37864479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experience of a 2-year spinal muscular atrophy NBS pilot study in Italy: towards specific guidelines and standard operating procedures for the molecular diagnosis.
    Abiusi E; Vaisfeld A; Fiori S; Novelli A; Spartano S; Faggiano MV; Giovanniello T; Angeloni A; Vento G; Santoloci R; Gigli F; D'Amico A; Costa S; Porzi A; Panella M; Ticci C; Daniotti M; Sacchini M; Boschi I; Dani C; Agostiniani R; Bertini E; Lanzone A; Lamarca G; Genuardi M; Pane M; Donati MA; Mercuri E; Tiziano FD;
    J Med Genet; 2023 Jul; 60(7):697-705. PubMed ID: 36414255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [(S)un (M)ay (A)rise on SMA : the hope of a region without spinal muscular atrophy].
    Boemer F; Caberg JH; Dideberg V; Beckers P; Marie S; Marcelis L; Bours V; Dangouloff T; Servais L
    Rev Med Liege; 2019 Sep; 74(9):461-464. PubMed ID: 31486315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Newborn screening of neuromuscular diseases.
    Dangouloff T; Boemer F; Servais L
    Neuromuscul Disord; 2021 Oct; 31(10):1070-1080. PubMed ID: 34620514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Newborn Screening for Spinal Muscular Atrophy: A 2.5-Year Experience in Hyogo Prefecture, Japan.
    Sonehara S; Bo R; Nambu Y; Iketani K; Lee T; Shimomura H; Ueda M; Takeshima Y; Iijima K; Nozu K; Nishio H; Awano H
    Genes (Basel); 2023 Dec; 14(12):. PubMed ID: 38137033
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Saffari A; Cannet C; Blaschek A; Hahn A; Hoffmann GF; Johannsen J; Kirsten R; Kockaya M; Kölker S; Müller-Felber W; Roos A; Schäfer H; Schara U; Spraul M; Trefz FK; Vill K; Wick W; Weiler M; Okun JG; Ziegler A
    Orphanet J Rare Dis; 2021 Oct; 16(1):441. PubMed ID: 34670613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Denaturing high-performance liquid chromatography coupled with multiplex PCR for rapid detection of large duplications or deletions in patients with Duchenne muscular dystrophy and spinal muscular atrophy].
    Zou HQ; Zhao BJ; Yan J; Han W; Xiong MH; Peng KR
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):686-9. PubMed ID: 23225050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overview of gene therapy in spinal muscular atrophy and Duchenne muscular dystrophy.
    Abreu NJ; Waldrop MA
    Pediatr Pulmonol; 2021 Apr; 56(4):710-720. PubMed ID: 32886442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variability in Newborn Screening Across Canada: Spinal Muscular Atrophy and Beyond.
    Groulx-Boivin E; Osman H; Chakraborty P; Lintern S; Oskoui M; Selby K; Van Caeseele P; Wyatt A; McMillan HJ
    Can J Neurol Sci; 2024 Mar; 51(2):203-209. PubMed ID: 36892082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Early Care (0-3 Years) In Duchenne Muscular Dystrophy Meeting Report.
    Armstrong N; Apkon S; Berggren KN; Braun C; Ciafaloni E; Connolly A; Kennedy A; Kuntz N; Mathews K; McGuire M; Parad R; Scavina M; Scharf RJ; Waldrop M
    J Neuromuscul Dis; 2024; 11(2):525-533. PubMed ID: 38189762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene therapy for selected neuromuscular and trinucleotide repeat disorders - An insight to subsume South Asia for multicenter clinical trials.
    Wijekoon N; Gonawala L; Ratnayake P; Sirisena D; Gunasekara H; Dissanayake A; Senanayake S; Keshavaraj A; Hathout Y; Steinbusch HWM; Mohan C; Dalal A; Hoffman E; D de Silva KR
    IBRO Neurosci Rep; 2023 Jun; 14():146-153. PubMed ID: 36819775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrating newborn screening for spinal muscular atrophy into health care systems: an Australian pilot programme.
    D'Silva AM; Kariyawasam DST; Best S; Wiley V; Farrar MA;
    Dev Med Child Neurol; 2022 May; 64(5):625-632. PubMed ID: 34839535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole-body vibration training in children with Duchenne muscular dystrophy and spinal muscular atrophy.
    Vry J; Schubert IJ; Semler O; Haug V; Schönau E; Kirschner J
    Eur J Paediatr Neurol; 2014 Mar; 18(2):140-9. PubMed ID: 24157400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for Duchenne muscular dystrophy in Germany, 1977-2011: A personal story.
    Scheuerbrandt G
    Muscle Nerve; 2018 Feb; 57(2):185-188. PubMed ID: 28981144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current and emerging therapies for Duchenne muscular dystrophy and spinal muscular atrophy.
    Iftikhar M; Frey J; Shohan MJ; Malek S; Mousa SA
    Pharmacol Ther; 2021 Apr; 220():107719. PubMed ID: 33130193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolving approaches to prenatal genetic counseling for Spinal Muscular Atrophy in the new treatment era.
    Zettler B; Estrella E; Liaquat K; Lichten L
    J Genet Couns; 2022 Jun; 31(3):803-814. PubMed ID: 35037741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Report of MDA muscle disease symposium on newborn screening for Duchenne muscular dystrophy.
    Mendell JR; Lloyd-Puryear M
    Muscle Nerve; 2013 Jul; 48(1):21-6. PubMed ID: 23716304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developmental progress in Duchenne muscular dystrophy: lessons for earlier detection.
    Parsons EP; Clarke AJ; Bradley DM
    Eur J Paediatr Neurol; 2004; 8(3):145-53. PubMed ID: 15120686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.